1. Dubeau L: The cell of origin of ovarian epithelial tumours. Lancet Oncol 9(12): 1191-1197, 2008.
  2. Yancik R: Ovarian cancer: age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer 71(2 Suppl): 517-23, 1993.
  3. American Cancer Society: Cancer Facts & Figures 2018. Atlanta, GA: American Cancer Society, 2018. Available from Website Policy
  4. American Joint Committee on Cancer: AJCC Cancer Staging Manual(8 ed.). Chicago, IL: American Joint Committee on Cancer, 2017.
  5. Genetic and Rare Diseases Information Center: Fallopian Tube Cancer. Gaithersburg, MD: National Institutes of Health, 2015. Available from
  6. Surveillance, Epidemiology, and End Results Program: Cancer Stat Facts: Ovarian Cancer. Bethesda, MD: National Institutes of Health, 2016. Available from
  7. Howlader N, Noone AM, Krapcho M, Miller D, Dishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA: SEER Cancer Statistics Review, 1975-2015, Bethesda, MD, 2017.
  8. Aarnio M, et al.: Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81(2): 214-8, 1999.
  9. Watson P, et al.: The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 123(2): 444-449, 2008.
  10. Pearce CL, et al.: Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 13(4): 385-94, 2012.
  11. Modugno F, et al.: Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol 191(3): 733-40, 2004.
  12. Miki Y, et al.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182): 66-71, 1994.
  13. Wooster R, et al.: Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559): 789-92, 1995.
  14. La Vecchia C: Ovarian cancer: Epidemiology and risk factors. Eur J Cancer Prev 26(1): 55-62, 2017.
  15. National Cancer Institute: Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ) - Health Professional Version. Bethesda, MD: National Institutes of Health, 2018. Available from
  16. Heintz AP, et al.: Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95(Suppl 1): S161-92, 2006.
  17. Prat J: Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 124(1): 1-5, 2014.
  18. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer(Version 2). Fort Washington, PA: National Comprehensive Cancer Network, 2018.
  19. National Cancer Institute: Cancer Trends Progress Report. Bethesda, MD: National Institutes of Health, 2018. Available from

Updated: June 8, 2018